⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21467045 | 1.00 | CHRM5 (0.39) | — | |
| SCHEMBL169425 | 1.00 | — | — | |
| SCHEMBL497934 | 0.96 | — | — | |
| SCHEMBL602116 | 0.89 | — | — | |
| SCHEMBL2686980 | 0.88 | CHRM5 (0.33) | — | |
| SCHEMBL13817489 | 0.86 | SIGMAR1 (0.34) | — | |
| SCHEMBL14616112 | 0.84 | SIGMAR1 (0.33) | — | |
| SCHEMBL14472942 | 0.82 | ALDH1A1 (0.44) | — | |
| SCHEMBL322743 | 0.81 | — | — | |
| SCHEMBL18691426 | 0.78 | EPHX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180008523-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | DEVICEFARM INC (US) | 2018-01-11 | — | — | US | claimed |
| US-20180000937-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | DEVICEFARM INC (US) | 2018-01-04 | — | — | US | claimed |
| US-20170361078-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-21 | — | — | US | claimed |
| US-20170354616-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-14 | — | — | US | claimed |
| US-20170354815-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-14 | — | — | US | claimed |
| EP-2044192-A2 | ENHANCED OXYGEN CELL CULTURE PLATFORMS | University of Miami (US) | 2009-04-08 | — | — | EP | claimed |
| WO-2008006104-A2 | ENHANCED OXYGEN CELL CULTURE PLATFORMS | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080009027-A1 | Enhanced Oxygen Cell Culture Platforms | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | US | claimed |
| US-20250009652-A1 | COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS | PEARL THERAPEUTICS, INC. | 2025-01-09 | — | — | US | disclosed |
| US-20240252439-A1 | PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE | HUNG MING CHIEN (TW) | 2024-08-01 | — | — | US | disclosed |
| US-20240024229-A1 | COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | PEARL THERAPEUTICS, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20230340506-A1 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-26 | — | — | US | disclosed |
| CN-110914416-B | Microorganism and method for producing cannabinoids and cannabinoid derivatives | 加州大学董事会 | 2023-07-21 | — | — | CN | disclosed |
| CN-115942959-A | Pharmaceutical composition for improving respiratory system injury and application of pharmaceutical composition for improving respiratory system injury | 洪铭谦 | 2023-04-07 | — | — | CN | disclosed |
| WO-2000045855-A2 | DIAGNOSTIC IMAGING OF LYMPH STRUCTURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-08-10 | — | — | WO | disclosed |
| EP-1019021-A1 | STABILIZED PREPARATIONS FOR USE IN METERED DOSE INHALERS | Inhale Therapeutic Systems, Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| EP-1019022-A1 | PERFORATED MICROPARTICLES AND METHODS OF USE | Inhale Therapeutic Systems, Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999016419-A9 | PERFORATED MICROPARTICLES AND METHODS OF USE | ALLIANCE PHARMA (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1999016422-A1 | STABILIZED PREPARATIONS FOR USE IN METERED DOSE INHALERS | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1999016419-A1 | PERFORATED MICROPARTICLES AND METHODS OF USE | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 1999-04-08 | — | — | WO | disclosed |